NEWTOWN, PENNSYLVANIA AND VANCOUVER, BRITISH COLUMBIA, September 4, 2014 – Helius Medical Technologies, Inc. (CSE: HSM) (“Helius” or the “Company”) is pleased to announce its participation in the upcoming Global Investment Conference sponsored by Peter Schiff’s Euro Pacific Capital on Tuesday, September 9, 2014.
At the conference, the Company will provide a presentation on the clinical and regulatory development of it PoNS device seeking regulatory approval for the treatment of neurological symptoms caused by disease or trauma. Philippe Deschamps, the Company’s CEO, will be on hand to meet with shareholders, potential investors, and analysts. The conference is being held at the Sofitel New York Hotel, 45 West 44th Street New York, NY 10036. For more information on the conference, please visit www.europac.net.
For further information, please contact:
Phil Deschamps, President, CEO & Director
Helius Medical Technologies, Inc.
CAUTIONARY DISCLAIMER STATEMENT: The Canadian Securities Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this news release.